- Home
- NSSC vs AMLX Comparison
NSSC vs AMLX Comparison
Compare NSSC & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSSC | AMLX |
|---|---|---|
| Founded | 1969 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | NSSC | AMLX |
|---|---|---|
| Price | $38.05 | $16.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $47.50 | $17.43 |
| AVG Volume (30 Days) | 306.4K | ★ 1.7M |
| Earning Date | 02-03-2026 | 03-03-2026 |
| Dividend Yield | ★ 1.45% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.23 | N/A |
| Revenue | ★ $186,786,000.00 | N/A |
| Revenue This Year | $13.13 | N/A |
| Revenue Next Year | $9.55 | N/A |
| P/E Ratio | $31.39 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $19.00 | $2.60 |
| 52 Week High | $48.12 | $16.96 |
Technical Indicators
Market Signals| Indicator | NSSC | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 33.56 | 75.12 |
| Support Level | $39.20 | $12.08 |
| Resistance Level | $43.19 | $12.50 |
| Average True Range (ATR) | 1.29 | 0.92 |
| MACD | -0.44 | 0.47 |
| Stochastic Oscillator | 7.73 | 92.46 |
Price Performance
Historical ComparisonAbout NSSC NAPCO Security Technologies Inc.
NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.